Naveen Pemmaraju Selected Research

Naveen Pemmaraju Research Topics

Disease

78	Neoplasms (Cancer) 02/2024 - 10/2013
76	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2023 - 08/2011
29	Primary Myelofibrosis (Myelosclerosis) 04/2024 - 09/2014
19	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2023 - 01/2015
18	Leukemia 10/2023 - 01/2015
17	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2024 - 07/2012
14	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2024 - 12/2014
13	Hematologic Neoplasms (Hematological Malignancy) 04/2024 - 01/2017
12	Philadelphia Chromosome 06/2023 - 02/2015
10	Thrombocytopenia (Thrombopenia) 01/2023 - 01/2018
9	Exanthema (Rash) 11/2023 - 11/2015
8	Infections 11/2023 - 11/2015
7	Anemia 04/2024 - 09/2014
6	Splenomegaly 11/2023 - 10/2014
6	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2023 - 10/2013
6	Fibrosis (Cirrhosis) 06/2022 - 07/2018
6	Residual Neoplasm 01/2021 - 12/2014
5	Disease Progression 05/2024 - 01/2018
5	Nausea 11/2023 - 02/2015
5	Hemorrhage 01/2023 - 01/2015
5	Cytopenia 01/2023 - 09/2019
5	Capillary Leak Syndrome 12/2021 - 01/2019
5	Pathologic Complete Response 07/2020 - 11/2015
4	Neutropenia 04/2024 - 01/2021
4	Hypertension (High Blood Pressure) 01/2023 - 11/2015
4	Pancreatitis 01/2023 - 11/2015
4	Pleural Effusion (Pleural Effusions) 11/2022 - 01/2014
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2021 - 01/2019
4	Acute Promyelocytic Leukemia 01/2021 - 08/2013
3	Thrombosis (Thrombus) 11/2023 - 11/2022
3	B-Cell Lymphoma (Lymphoma, B Cell) 11/2023 - 01/2019
3	Myocardial Infarction 01/2023 - 11/2015
3	Hypoalbuminemia 10/2022 - 01/2019
3	Edema (Dropsy) 12/2021 - 01/2019
3	Fatigue 01/2021 - 01/2018
3	Blast Crisis (Blast Phase) 01/2021 - 11/2020
2	Polycythemia (Erythrocytosis) 02/2024 - 01/2023
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2023 - 02/2015
2	Chromosome Aberrations (Chromosome Abnormalities) 11/2022 - 01/2018

Drug/Important Bio-Agent (IBA)

35	venetoclaxIBA 04/2024 - 01/2017
19	tagraxofuspIBA 04/2024 - 07/2014
17	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2023 - 11/2013
17	ruxolitinibIBA 01/2023 - 03/2015
14	Azacitidine (5 Azacytidine)FDA Link 12/2023 - 01/2015
13	Decitabine FDA Link 01/2022 - 09/2015
12	Tyrosine Kinase InhibitorsIBA 01/2023 - 07/2012
9	Dasatinib (BMS 354825)FDA Link 04/2024 - 07/2012
7	Janus Kinase InhibitorsIBA 11/2023 - 01/2015
7	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 11/2023 - 11/2013
7	Core Binding Factors (Core-Binding Factor)IBA 01/2023 - 04/2016
7	Hemoglobins (Hemoglobin)IBA 01/2023 - 09/2014
6	Interleukin-3 Receptors (Interleukin 3 Receptor)IBA 12/2023 - 07/2014
6	Cladribine FDA LinkGeneric 11/2023 - 01/2014
6	ponatinibIBA 10/2023 - 09/2015
6	Transaminases (Aminotransferases)IBA 01/2023 - 02/2015
5	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2017
5	BilirubinIBA 11/2023 - 02/2015
5	Inotuzumab OzogamicinIBA 06/2023 - 01/2018
5	fludarabineIBA 01/2023 - 11/2017
5	Clofarabine (Clolar)FDA Link 01/2021 - 11/2013
4	navitoclaxIBA 11/2023 - 01/2022
4	Sorafenib (BAY 43-9006)FDA Link 11/2023 - 01/2019
4	ibrutinibIBA 01/2023 - 01/2019
4	CytokinesIBA 01/2023 - 10/2019
4	NivolumabIBA 01/2023 - 01/2019
4	Rituximab (Mabthera)FDA Link 12/2021 - 02/2015
4	Vincristine (Oncovin)FDA LinkGeneric 12/2018 - 02/2015
3	Chimeric Antigen ReceptorsIBA 01/2023 - 05/2022
3	Phosphotransferases (Kinase)IBA 01/2023 - 01/2017
3	Gemtuzumab (Mylotarg)FDA Link 11/2022 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2017
3	InterferonsIBA 01/2022 - 12/2020
3	fms-Like Tyrosine Kinase 3IBA 01/2022 - 07/2014
3	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2022 - 10/2019
3	Alanine Transaminase (SGPT)IBA 08/2021 - 11/2015
3	Lenalidomide (CC 5013)FDA Link 01/2021 - 01/2015
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2019 - 11/2015
3	Prednisone (Sone)FDA LinkGeneric 12/2018 - 09/2014
3	Janus KinasesIBA 01/2017 - 01/2015
3	Imatinib Mesylate (Gleevec)FDA Link 11/2016 - 07/2012
3	nilotinib FDA Link 11/2016 - 07/2012
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 04/2024 - 08/2013
2	Interleukin-3 (Interleukin 3)IBA 12/2023 - 10/2019
2	Diphtheria ToxinIBA 12/2023 - 10/2019
2	Hydroxyurea (Hydrea)FDA LinkGeneric 11/2023 - 01/2023
2	CPX-351IBA 11/2023 - 11/2020
2	PLX51107IBA 11/2023 - 01/2022
2	Apoptosis Regulatory ProteinsIBA 10/2023 - 01/2019
2	blinatumomabIBA 06/2023 - 01/2019
2	NucleophosminIBA 01/2023 - 08/2013
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 11/2022 - 01/2021
2	11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA 11/2022 - 01/2022

Therapy/Procedure

87	Therapeutics 11/2023 - 07/2012
38	Drug Therapy (Chemotherapy) 05/2024 - 08/2011
6	Immunotherapy 05/2022 - 01/2017
5	Stem Cell Transplantation 01/2023 - 05/2015
4	Induction Chemotherapy 01/2022 - 01/2016
3	Cell Transplantation 01/2023 - 03/2019
3	Drug Tapering 01/2020 - 01/2018
2	Hematopoietic Stem Cell Transplantation 01/2023 - 08/2013